Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction(STEMI) treated with pharmaco-invasive strategy with half–dose recombinant human prourokinase (PHDP): Two-year outcomes

Hui-Hui Yang, Jie Dou, Yong-Hua Liu,Dong-Lei Luo

Asian Journal of Surgery(2024)

引用 0|浏览0
暂无评分
关键词
Recombinant human prourokinase,Primary percutaneous coronary intervention,Acute ST-Segment elevation myocardial infarction,Major adverse cardiovascular and cerebrovascular events,Follow up
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要